For Network Marketing Leaders
The next great
superfood hero
ingredient.
Patented. Clinically supported. On trend across protein, fiber, antioxidants, and gut health, with a mild flavor profile that works across formulations. Zivolife is looking for its go-to-market partner in the direct selling industry.
The opportunity
Every great superfood wave
started with one company.
Noni. Acai. Mangosteen. Each became a defining chapter in direct selling history, built on real science, distributor conviction, and a story the market was ready for. Zivolife carries the same wave mechanics, with something none of them had: patent protection and a genuine supply moat.
Late 1990s
Noni
Tahitian Noni
Real bioactives. Real early distributor conviction. Distributors built serious downlines around a compelling health story the market was hungry for.
Mid 2000s
Acai
MonaVie
One of the fastest-growing direct selling launches of its era. Acai's antioxidant story created enormous distributor excitement in just a few years.
Late 2000s
Mangosteen
XanGo
XanGo built a major direct selling business around a single exotic fruit. The distributor excitement was real, the launch momentum undeniable.
Now
Zivolife
The one with a moat.
Same wave mechanics: extraordinary science, a compelling distributor story, premium price justification, and a market primed across gut health, protein, fiber, and whole-food nutrition.
The question is not whether Zivolife becomes the next hero ingredient in this industry. The question is which company moves first.
The organism
500 million years
in the making.
Klebsormidium flaccidum var. ZL01
Zivolife is not spirulina. It is not chlorella. It belongs to the Charophyte class, the evolutionary lineage that bridged aquatic life and all land plants on Earth approximately 500 million years ago. That lineage produces a bioactive compound profile that simply does not exist in other commercial microalgae ingredients.
Why it is categorically different
Spirulina is a prokaryote with no cell wall and no land-plant biochemistry. Chlorella sits on an entirely separate evolutionary branch. Zivolife is a Charophyte, the class from which every land plant on Earth descends. That distinction is mechanistic, not marketing.
What that means for your formulation
Zivolife delivers meaningfully higher beta-glucan content than spirulina or chlorella, a complete plant protein profile with all nine essential amino acids, and prebiotic dietary fiber from a whole-food source. The compound profile is a direct consequence of the Charophyte cell wall architecture.
The formulation advantage
Spirulina and chlorella require flavor masking in virtually every application. Zivolife is mild, neutral, and flavor-adaptive, working in shakes, bars, capsules, gels, and beverages without compromise. One whole-food ingredient. Multiple product formats.
The whole-food advantage
Zivolife is not a blend, a formula, or a multi-ingredient stack. It is a single whole plant, delivered complete and unaltered. For distributors, that is a story that cuts through a category crowded with complexity.
Why it is defensible
Three things that
cannot be replicated.
A great ingredient story builds excitement. Structural exclusivity protects it. Zivolife has three independent layers of protection. Each alone would be unusual in the ingredient market. Together they are unprecedented in direct selling.
The only commercially cultivated Charophyte in the world
Zivolife is cultivated at two purpose-built facilities in the Americas. The strain took decades of selective cultivation to develop. There is no alternate producer. This natural exclusivity exists independently of patent protection.
U.S. patent protection on the specific strain
Zivolife is protected by issued U.S. patents covering applications of Klebsormidium flaccidum var. ZL01 specifically. Not a broad category. Not a generic compound. This strain. A partner who launches with Zivolife owns a story no competitor can legally replicate.
Published strain-specific research
Peer-reviewed molecular research has identified bioactive compounds with anti-inflammatory activity in Klebsormidium flaccidum var. ZL01 biomass (Qiu et al., 2020). Strain-specific mechanistic science is rare in the commercial microalgae category.
Five stories in one ingredient
The story that
sells itself at the kitchen table.
The best network marketing products have always had one thing: a story you can tell in 90 seconds that makes someone feel like they would be foolish to wait. Zivolife has five of those stories built into a single hero ingredient.
"This is the next superfood wave, and it is proprietary."
Distributors who lived through the Noni, Acai, and Mangosteen years know the wave pattern. They built real downlines and real income around a great story. Zivolife gives them that same energy, with patent protection and single-source supply that means the story cannot be undercut. That is a distributor conversation no previous superfood wave could have had.
The gut health story
Gut health is one of the top wellness trends globally. Consumers are actively seeking prebiotic fiber, and most Americans fall short of their daily requirement. Zivolife delivers prebiotic beta-glucan fiber from a whole-food source, not an isolated extract. No education required. The audience is already primed.
The fiber story
Fiber is being called the next protein. Zivolife delivers dietary fiber including a meaningful beta-glucan fraction, a direct consequence of Charophyte cell wall architecture that spirulina cannot replicate. At a moment when major consumer brands are racing to lead on fiber, this is a story with runway.
The protein story
Complete plant protein with all nine essential amino acids, zero cholesterol, fully vegan. For a meal replacement or nutrition bar launch, Zivolife lets your product lead with a protein story, a fiber story, and a superfood story, all in a single whole-food ingredient.
The whole-food story
In a category defined by multi-ingredient blends and reconstructed nutrition, Zivolife is one whole plant. Complete and unaltered. That positioning connects directly to the shift in how consumers think about nutrition, and it becomes a daily autoship anchor rather than a short-course protocol.
The anti-inflammatory story
The clinical lineage from which Zivolife was isolated has peer-reviewed human RCT data supporting healthy inflammatory response markers, healthy lipid profiles, and healthy metabolic markers over ten weeks (Oben et al., 2007). For distributors selling to longevity and cardiovascular wellness customers, that clinical foundation is rare.
The evidence
Real science.
On the actual plant.
Zivolife sits within a published research lineage that includes strain-specific mechanistic work on Klebsormidium flaccidum var. ZL01 and human clinical research on the preparation from which the strain was isolated. That distinction matters for the confidence with which your distributors can tell the story.
Peer-reviewed molecular research has identified bioactive compounds with anti-inflammatory activity in Klebsormidium flaccidum var. ZL01 biomass, including carotenoids, glycoglycerolipids, and hydroxylated fatty acids.
Qiu et al., 2020 — Molecules Journal
A randomised, double-blind, placebo-controlled human trial on the clinical preparation from which Zivolife was isolated documented statistically significant support for healthy inflammatory markers, healthy lipid profiles, and healthy metabolic markers over ten weeks.
Oben et al., 2007 — Lipids in Health and Disease
Peer-reviewed toxicology research supports a strong safety profile for Zivolife at daily consumption levels. Non-mutagenic, non-allergenic, with a wide safety margin relative to recommended serving size.
Published peer-reviewed toxicology
Every commercial lot is independently tested by Eurofins to AOAC and USP standards. Certificate of Analysis available under NDA. Full regulatory documentation available for partner review.
Eurofins USA — per-lot verification
Two issued U.S. patents cover weight management, anti-inflammatory, and immunomodulatory applications of Zivolife specifically. Public record. No workaround exists.
USPTO — available on request
Self-affirmed GRAS. cGMP and HACCP certified facilities. FDA FSVP validated. Non-GMO, Gluten-Free, and Vegan certified. Full regulatory package available for partner diligence under NDA.
Available under NDA
The white space
A category
nobody in this industry owns.
Daily whole-food nutrition that supports gut integrity, inflammatory response, and absorption is one of the fastest-growing consumer wellness conversations, and one of the largest unaddressed gaps in direct selling portfolios. Zivolife does not bolt these claims on as secondary benefits. They are the mechanism of the plant itself.
A daily autoship story, not a short-course protocol
Because Zivolife works as a whole food rather than a targeted supplement, it positions as a daily wellness anchor rather than a periodic cleanse. That is the difference between a 30-day program and a recurring autoship, and the difference in lifetime customer value is substantial.
A category white space you can own
A whole-food microalgae ingredient with clinical documentation and this compound profile does not exist anywhere in direct selling today. A Zivolife-anchored launch would be category-creating, not a reformulation of something already in your competitor's lineup.
An ingredient that works across formats
Shakes, bars, capsules, gels, beverages. Zivolife is mild, neutral, and flavor-adaptive, which means one hero ingredient can anchor an entire product family without flavor-masking complications.
Timing advantage for first movers
Gut health, fiber, and whole-food nutrition are converging as the dominant consumer wellness conversations of this decade. Zivolife is ready for market now. The window for being first in your segment is the window that matters.
Head to head
Zivolife vs.
every alternative.
Your distributors will be asked: why not just use spirulina? This is the answer, built into your product story from day one.
| Factor | Zivolife | Spirulina | Chlorella | Generic greens |
|---|---|---|---|---|
| U.S. patent protection | ✓ Yes | ✗ No | ✗ No | ✗ No |
| Strain-specific peer-reviewed research | ✓ Yes | ✗ Commodity research only | ✗ Commodity research only | ✗ No |
| Beta-glucan and prebiotic fiber | ✓ Meaningfully higher | ✗ Lower | ~ Moderate | ✗ Variable |
| Cyanotoxin risk | ✓ None (Charophyte) | ✗ Potential risk | ✓ None | ✗ Depends on source |
| Taste and formulation flexibility | ✓ Mild, neutral, adaptive | ✗ Strong, fishy | ✗ Earthy, bitter | ~ Variable |
| Brand story potential | ✓ "Made with Zivolife" | ✗ "Contains algae" | ✗ "Contains algae" | ✗ Undifferentiated |
Supply chain
Purpose-built facilities.
Full transparency.
Single-species cultivation
Facilities produce Klebsormidium flaccidum exclusively. No shared equipment with other algae species. No cross-contamination risk. Full batch traceability from cultivation through export documentation on every commercial lot.
Third-party tested, every lot
Every commercial lot is independently tested by Eurofins to AOAC and USP standards before release. Certificate of Analysis available under NDA. Zero cyanotoxins confirmed on every lot as a documented result, not a policy statement.
Full regulatory documentation
Self-affirmed GRAS. cGMP and HACCP certified facilities. FDA FSVP validated. Non-GMO, Gluten-Free, and Vegan certified. Full regulatory package available for partner diligence under NDA.
The timing question
We are looking for
our go-to-market
partner.
We are not running a broad RFQ. We are having focused conversations with direct selling companies that have the brand positioning, product development capability, and distribution strength to make a Zivolife launch a defining new product moment.
Every major superfood wave in this industry rewarded the company that moved in the first twelve months. The brands that built their identity around Noni, Acai, and Mangosteen early built enduring distributor loyalty. The ones who waited found themselves telling a story their competitors had already told.
Zivolife is patented, clinically supported, and on trend across every major consumer wellness category right now. The window for being first in your segment is open. It will not stay open indefinitely.
Get in TouchWe are currently in active discussions with companies across the sports nutrition, functional food, and gut health categories within direct selling. We do not disclose partner conversations, but we do disclose that the window for first-mover positioning is finite. Full technical documentation, Certificate of Analysis, and regulatory package available under NDA.
Get in touch
Let us find out
if this is the right fit.
We are having focused conversations with companies that have the brand positioning and product development capacity to make a Zivolife launch meaningful. If that sounds like you, reach out directly.
team@zivo.life